School of Pharmacy and Department of Chemistry, University of Wisconsin, 777 Highland Avenue, Madison, Wisconsin 53705, USA.
J Pharm Sci. 2010 Sep;99(9):4023-31. doi: 10.1002/jps.22251.
A previous method for measuring solubilities of crystalline drugs in polymers has been improved to enable longer equilibration and used to survey the solubilities of indomethacin (IMC) and nifedipine (NIF) in two homo-polymers [polyvinyl pyrrolidone (PVP) and polyvinyl acetate (PVAc)] and their co-polymer (PVP/VA). These data are important for understanding the stability of amorphous drug-polymer dispersions, a strategy actively explored for delivering poorly soluble drugs. Measuring solubilities in polymers is difficult because their high viscosities impede the attainment of solubility equilibrium. In this method, a drug-polymer mixture prepared by cryo-milling is annealed at different temperatures and analyzed by differential scanning calorimetry to determine whether undissolved crystals remain and thus the upper and lower bounds of the equilibrium solution temperature. The new annealing method yielded results consistent with those obtained with the previous scanning method at relatively high temperatures, but revised slightly the previous results at lower temperatures. It also lowered the temperature of measurement closer to the glass transition temperature. For D-mannitol and IMC dissolving in PVP, the polymer's molecular weight has little effect on the weight-based solubility. For IMC and NIF, the dissolving powers of the polymers follow the order PVP > PVP/VA > PVAc. In each polymer studied, NIF is less soluble than IMC. The activities of IMC and NIF dissolved in various polymers are reasonably well fitted to the Flory-Huggins model, yielding the relevant drug-polymer interaction parameters. The new annealing method yields more accurate data than the previous scanning method when solubility equilibrium is slow to achieve. In practice, these two methods can be combined for efficiency. The measured solubilities are not readily anticipated, which underscores the importance of accurate experimental data for developing predictive models.
一种改进的先前用于测量结晶药物在聚合物中溶解度的方法,可实现更长的平衡时间,并用于调查吲哚美辛(IMC)和硝苯地平(NIF)在两种均聚物(聚乙烯吡咯烷酮(PVP)和聚醋酸乙烯酯(PVAc))及其共聚物(PVP/VA)中的溶解度。这些数据对于理解无定形药物-聚合物分散体的稳定性很重要,这是一种积极探索用于输送难溶性药物的策略。由于聚合物的高粘度会阻碍达到溶解度平衡,因此在聚合物中测量溶解度很困难。在该方法中,通过冷冻研磨制备的药物-聚合物混合物在不同温度下退火,并通过差示扫描量热法进行分析,以确定是否存在未溶解的晶体,从而确定平衡溶液温度的上限和下限。与先前的扫描方法相比,新的退火方法在相对较高的温度下得到了一致的结果,但在较低的温度下对先前的结果进行了略微修正。它还降低了测量温度,使其更接近玻璃化转变温度。对于在 PVP 中溶解的 D-甘露醇和 IMC,聚合物的分子量对基于重量的溶解度影响不大。对于 IMC 和 NIF,聚合物的溶解能力依次为 PVP>PVP/VA>PVAc。在研究的每种聚合物中,NIF 的溶解度均小于 IMC。在各种聚合物中溶解的 IMC 和 NIF 的活性与 Flory-Huggins 模型拟合得相当好,得出了相关的药物-聚合物相互作用参数。当达到溶解度平衡缓慢时,新的退火方法比先前的扫描方法产生更准确的数据。实际上,可以将这两种方法结合使用以提高效率。测量的溶解度不易预测,这突显了准确的实验数据对于开发预测模型的重要性。